Other
Eli Lily (LLY) says will vigorously defend in Novo Nordisk (NOVOB DC) lawsuit
StockNow breaking-news AI analysis
Novo Nordisk sued Eli Lilly today for deceptive advertising, claiming Lilly's GLP-1 ads misrepresent clinical data by comparing its highest doses to outdated, lower doses of Novo's medications.
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
